Tirofiban provides 'platelet anesthesia' during cardiopulmonary bypass in baboons

Journal of Thoracic and Cardiovascular Surgery

Volumn 113, Issue 1, 1997, Pages 182-193

  Hiramatsu, Y ^a   Gikakis, N ^a   Anderson III, H L ^a   Gorman III, J H ^a   Marcinkiewicz, C ^a   Gould, R J ^a   Niewiarowski, S ^a   Edmunds L H , Jr ^a   Bidstrup, B P ^a   Kirklin, J K ^a   Verrier, E D ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; BETA THROMBOGLOBULIN; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCOPROTEIN IIIA; HEPARIN; PROTAMINE; TIROFIBAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BABOON; BLEEDING TIME; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; DOSE RESPONSE; HEMODYNAMICS; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION;

EID: 18144439851     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(97)70414-8     Document Type: Article

References (27)

1. RC Woodman LA. Harker Bleeding complication associated with cardiopulmonary bypass Blood 76 1990 1680 1697
2. LA Harker TW Malpass HE Branson EA Hessel II SJ. Slichter Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective α-granule release Blood 56 1980 824 834
3. N Ellison LH Edmunds Jr RW. Colman Platelet aggregation following heparin and protamine administration Anesthesiology 48 1978 65 68
4. SF Khuri CR Valeri J Loscalzo Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass Ann Thorac Surg 60 1995 1008 1014
5. KH Teoh GT Christakis RD Weisel Dipyridamole preserved platelets and reduced blood loss after cardiopulmonary bypass 96 1988 332 341
6. JR Kappa CA Fisher B Todd Intraoperative management of patients with heparin-induced thrombocytopenia Ann Thorac Surg 49 1990 714 723
7. GA Marguerie EF Plow TS. Edgington Human platelets possess an inducible and saturable receptor specific for fibrinogen J Biol Chem 254 1979 5357 5363
8. J Hawiger S Timmons M Kloczewiak DD Strong RF. Doolittle γ and α chains of human fibrinogen possess sites reactive with human platelet receptors Proc Natl Acad Sci U S A 79 1982 2068 2071
9. RJ Gould MA Polokoff PA Friedman Disintegrins: a family of integrin inhibitory proteins from viper venoms Proc Soc Exp Biol Med 195 1990 168 171
10. BS Coller EI Peerschke LE Scudder CA. Sullivan A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa J Clin Invest 72 1983 325 338
11. TF Huang JC Holt H Lukasiewicz S. Niewiarowski Trigramin: a low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex J Biol Chem 262 1987 16157 16163
12. J Musial S Niewiarowski B Rucinski Inhibition of platelet adhesion to surfaces of extracorporeal circuits by disintegrins: RGD-containing peptides from viper venoms Circulation 82 1990 261 273
13. O Shigeta P Gluszko SW Downing W Lu S Niewiarowski LH Edmunds Jr. Protection of platelets during long-term extracorporeal membrane oxygenation in sheep with a single dose of a disintegrin Circulation 86 Suppl 1992 II398 II404
14. MS Egbertson CTC Chang ME Duggan Non-peptide fibrinogen receptor antagonists. 2. Optimization of a tyrosine template as a mimic for Arg-Gly-Asp J Med Chem 37 1994 2537 2551
15. RJ Gould CTC Chang RJ Lynch MK-383 is a potent non-peptide mimic of RGD that inhibits glycoprotein IIB/IIIA (abstract) Thromb Haemost 69 1993 976
16. K Peerlinck I de Lepeleire M Goldberg MK-383 (L-700,462), a selective non-peptide platelet glycoprotein IIb/IIIa antagonist, is active in man Circulation 88 Pt 1 1993 1512 1517
17. JS Barrett G Murphy K Peerlinck Pharmacokinetics and pharmacodynamics of MK-383, a selective non-peptide platelet glycoprotein-IIb/IIIa receptor antagonist, in healthy men Clin Pharmacol Ther 56 1994 377 388
18. ACA Carvalho RW Colman RS. Lees Platelet function in hyperlipoproteinemia N Engl J Med 290 1974 434 438
19. B Rucinski S Niewiarowski P James DA Walz Z. Budzynski Antiheparin proteins secreted by human platelets; purification, characterization and radioimmunoassay Blood 53 1979 47 62
20. MA McLane MA Kowalska L Silver SJ Shattil S. Niewiarowski Interaction of disintegrins with the αIIbβ3 receptor on resting and activated human platelets Biochem J 301 1994 429 436
21. JJ Cook M Trybulec EC Lasz S Khan S. Niewiarowski Binding of glycoprotein IIIa–derived peptide 217-231 to fibrinogen and von Willebrand factors and its inhibition by platelet glycoprotein IIb/IIIa complex Biochim Biophys Acta 1119 1992 312 321
22. VP Addonizio J Strauss III EJ Macarak RW Colman LH Edmunds Jr. Preservation of platelet number and function with prostaglandin during total cardiopulmonary bypass in rhesus monkeys Surgery 83 1978 1680 1697
23. J Lefkovits EF Plow EJ. Topol Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine N Engl J Med 332 1995 1553 1559
24. MD Boisclair DA Lane H Philippou Thrombin production, inactivation and expression during open heart surgery measured by assays for activation fragments including a new ELISA for prothrombin fragment F1+2 Thromb Haemost 70 1993 253 258
25. A Bernabei N Gikakis MA Kowalska S Niewiarowski LH Edmunds Jr. Iloprost and echistatin protect platelets during simulated extracorporeal circulation Ann Thorac Surg 59 1995 149 153
26. JE Tcheng RA Harrington K Kottke-Marchant Multicenter, randomized, double blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker integrelin in elective coronary intervention Circulation 91 1995 2151 2157
27. TM Reilly SA Mousa AL Racanelli A monoclonal antibody that recognizes the GPIIb/IIIa antagonist DMP 728 Arterioscler Thromb Vasc Biol 15 1995 2195 2199